Tech Company Financing Transactions
Bluestem Biosciences Funding Round
On 8/9/2022, Bluestem Biosciences raised $5 million in Seed financing from Invest Nebraska, private investors and Zero Infinity Partners.
Transaction Overview
Company Name
Announced On
8/9/2022
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to build a team and product discovery pipeline powered by its proprietary digital biology architecture.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
3555 Farnam St Fl 12 903
Omaha, NE 68131
USA
Omaha, NE 68131
USA
Phone
Website
Email Address
Overview
Bluestem Biosciences, Inc., is designing biology with the end in mind, to enable existing infrastructure in the Midwest for industrialized synthetic biology. We are leveraging digital biology to facilitate the discovery of biomanufacturing, focused on the sustainable production of chemicals and materials. Bluestem Biosciences was founded in January 2022 in Omaha, Nebraska.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Billy Hagstrom
Chief Technical Officer
Tyler Autera
VP - R & D
Jared Wenger
Browse more venture capital transactions:
Prev: 8/9/2022: Grizzly.fi venture capital transaction
Next: 8/9/2022: CreatorDAO venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs